Read this leaflet carefully before you start taking this medicine because it contains important information for you.
1.What Elvanse is and what it is used for
2.What you need to know before you start taking Elvanse
3.How to take Elvanse
4.Possible side effects
5.Storage of Elvanse
6.Contents of the pack and other information
What is Elvanse
Elvanse contains the active ingredient lisdexamfetamine dimesylate that acts on brain activity. It helps to improve attention, concentration, and reduce impulsivity.
Elvanse is a long-acting medication that acts gradually over 13 hours.
What is it used for
Elvanse is part of a comprehensive treatment program for "attention deficit hyperactivity disorder" (ADHD)
in children and adolescents aged 6 to 18 years in whom previous treatment with methylphenidate has been inadequate for ADHD.
You should inform your doctor if you do not feel better or feel worse after a month of treatment. Elvanse is not recommended for all patients with ADHD and the decision to use this medication is based on a thorough medical evaluation.
Elvanse is not indicated for the treatment of ADHD in children under 6 years of age as its safety and efficacy in such young individuals is unknown.
How Elvanse works
Elvanse improves the activity of certain parts of the brain that are underactive. The medication may help to improve attention, concentration, and reduce impulsive behavior.
The medication is administered as part of a treatment program that usually includes:
It can only be prescribed by doctors who have experience in treating individuals with behavioral problems.
About ADHD
People with ADHD have difficulties with:
These individuals are not to blame for being unable to do these things. However, ADHD can cause problems in daily life. Children and adolescents with ADHD may have difficulties learning and doing homework. They struggle to behave well at home, school, and other places.
ADHD does not affect a person's intelligence.
Do not take Elvanse if you present any of the circumstances indicated above. If you are unsure, consult your doctor or pharmacist before taking Elvanse, as it may worsen these problems.
Warnings and precautions
Consult your doctor or pharmacist before starting treatment with Elvanse if:
Or if you are a woman who may become pregnant, plans to become pregnant, or is pregnant (see the section “Pregnancy and breastfeeding”).
Inform your doctor or pharmacist if you present any of the circumstances indicated above before starting treatment. Elvanse may worsen these problems. Your doctor will want to monitor how the medication affects you.
If not used correctly, Elvanse may cause abnormal behavior and dependence on the medication. Inform your doctor if you or your child have ever abused alcohol, prescription medications, or drugs. Do not give this medication to anyone, even if they seem to have similar symptoms.
Elvanse may cause cardiac arrhythmias in some patients. If you experience palpitations or irregular heartbeats during treatment, you must inform your doctor immediately. The risk of cardiac problems may increase with increased dosage. Therefore, you should follow the recommended dosage.
Checks your doctor will make before you start taking Elvanse
These checks are made to decide if Elvanse is the right medication for you. Your doctor will ask you about:
It is essential to provide as much information as possible. This will help your doctor decide if Elvanse is the right medication for you. Your doctor may decide that further tests are needed before you start taking this medication.
Effect on weight
Use of Elvanse with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Do not take Elvanse if:
Elvanse may interact with other medications. If you take any of the following medications, consult your doctor or pharmacist before taking Elvanse:
If you are unsure if the medications you take are on the above list, consult your doctor or pharmacist before taking Elvanse.
Control of doping and use in athletes
Patients should be warned that this medication may produce a positive result in drug tests.
Pregnancy and breastfeeding
If you are pregnant, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medication.
Elvanse in the body is transformed into other substances that can cross the placenta and pass into breast milk.
The available data on the use of Elvanse during the first three months of pregnancy do not indicate an increased risk of congenital malformations in the child, but may increase the risk of preeclampsia (a condition that usually occurs after 20 weeks of pregnancy and is characterized by high blood pressure and protein in the urine) and premature birth. Newborns exposed to amphetamine during pregnancy may exhibit withdrawal symptoms (tremors, irritability, hypertonia). Do not use this medication during pregnancy unless your doctor explicitly tells you to, and do not breastfeed while taking Elvanse.
Driving and operating machinery
You may feel dizzy, have trouble focusing, or see blurry when taking Elvanse. If this happens, it is dangerous to engage in activities such as driving, operating machinery, riding a bike, horseback riding, or climbing trees.
Elvanse contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per capsule; it is essentially “sodium-free”.
How much to take
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Elvanse is only for you. Do not give this medication to anyone else, even if you have similar symptoms.
The maximum daily dose is 70 mg.
How to take Elvanse
• Take Elvanse in the morning before breakfast. It can be taken with or without food.
• There are two ways to take Elvanse:
or Swallow the capsule whole with a glass of water.
or Open the capsule and empty the contents into:
• a soft food such as yogurt
• a glass of water or orange juice
Use a spoon to break up any lump and mix Elvanse and the yogurt, water, or orange juice well. Take all the yogurt or drink all the water or orange juice immediately after mixing with Elvanse. Do not store it. Do not worry if there is a film left in the glass or container; it is not the active ingredient.
Dose
If you do not feel better after 1 month of treatment
If you do not feel better, inform your doctor. You may need a different treatment.
Abuse of Elvanse
• If you use Elvanse incorrectly, you may experience abnormal behavior or develop dependence on the medication. Therefore, inform your doctor if you have ever abused alcohol, prescription medications, or drugs, or if you have had dependence on any of these substances.
Take more Elvanse than you should
In case of overdose or accidental ingestion, consult a doctor, pharmacist, or call the Toxicology Information Service, phone 915620420, indicating the medication and the amount ingested.
The signs of overdose may include: restlessness, tremors, increased uncontrolled movements, muscle tremors, rapid breathing, confusion, tendency to fight or argue, see, feel, or hear things that are not real (hallucinations), panic state, high fever, or muscle collapse. You may then feel tired and depressed. Nausea, vomiting, diarrhea, and stomach cramps may also occur. Changes in heart rhythm (slow, fast, or irregular), high or low blood pressure, circulatory collapse, attacks, and coma may also occur.
Missed dose
Do not take a double dose to compensate for the missed dose. If you miss a dose, wait until the next day. Avoid taking the dose in the afternoon to prevent sleep disturbances (insomnia).
Stopping treatment with Elvanse
If you stop taking this medication, your ADHD symptoms may return.
Do not stop taking the medication without consulting your doctor. Do not stop taking the medication suddenly or on your own.
What your doctor will do while you are on Elvanse treatment
Your doctor will perform some tests
• Before starting: to ensure that Elvanse is safe and beneficial for you.
• After starting: your doctor will perform tests at least every 6 months, and even more often.
You will also be tested when you change doses. These tests will include:
-appetite control,
-height and weight measurement,
-blood pressure and pulse measurement,
-checking if you have had mood, emotional state, or any other abnormal feelings or if these issues have worsened while taking Elvanse.
Long-term treatment
Elvanse does not need to be taken forever. If you take Elvanse for more than a year, your doctor should interrupt the treatment for a short period, such as during vacations. This allows you to see if you still need the medication.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them. Your doctor will inform you about these side effects.
Some side effects can be serious. If any of the following side effects occur, seek medical attention immediately:
Frequent (may affect up to 1 in 10 people)
Less frequent (may affect up to 1 in 100 people)
Unknown frequency (cannot be estimated from available data)
If you experience any of the above side effects, seek medical attention immediately.
Other side effects include the following. If they become serious, inform your doctor or pharmacist:
Very frequent (may affect more than 1 in 10 people)
Frequent (may affect up to 1 in 10 people)
Less frequent (may affect up to 1 in 100 people)
Unknown frequency (cannot be estimated from available data)
*The following side effects have a different frequency in children and adolescents compared to adults.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Usewww.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Do not store at a temperature above 25°C.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the bottle and on the box after CAD. The expiration date is the last day of the month indicated.
Do not use this medication if the capsules show any type of damage.
Medications should not be disposed of through drains or in the trash. Dispose of the containers and medications you no longer need at the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of Elvanse
The active ingredient is lisdexamfetamine dimesylate.
Each hard capsule of 50 mg contains 50 mg of lisdexamfetamine dimesylate, corresponding to 14.8 mg of dexamfetamine.
The other components are :
• Hard capsule content:microcrystalline cellulose, croscarmellose sodium, magnesium stearate.
•Hard capsule coating:gelatin, black ink (shellac and iron oxide black (E172)).
•Colorants of the hard capsule coating:titanium dioxide (E171) and brilliant blue FCF (E133).
Appearance of the product and contents of the package
Hard capsules.
The 50 mg capsules have a white opaque body and a blue opaque cap, with the imprint “S489” and “50 mg” in black ink.
Package size: 28 or 30 capsules. Some package sizes may only be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
Takeda Pharmaceuticals International AG Ireland Branch
Block 2 Miesian Plaza
50-58 Baggot Street Lower
Dublín 2, D02 HW68, Ireland
E-mail: [email protected]
Responsible manufacturer:
Shire Pharmaceuticals Ireland Limited
Block 2 & 3 Miesian Plaza
50-58 Baggot Street Lower
Dublin 2
Ireland
or
Takeda Pharmaceuticals International AG Ireland Branch
Block 2 Miesian Plaza
50 – 58 Baggot Street Lower
Dublín 2, D02 HW68
Ireland
or
Takeda GmbH,
Plant Oranienburg, Lehnitzstrasse 70-98,
16515 Oranienburg
Germany
Further information about this medicinal product can be obtained from the local representative of the marketing authorization holder:
Takeda Farmacéutica España S.A.
Calle Albacete, 5, planta 9ª,
Edificio Los Cubos
28027 Madrid
Spain
Tel: +34 91 790 42 22
This medicinal product is authorized in the Member States of the European Economic Area and inUnited Kingdom (Northern Ireland)with the following names:
GermanyElvanse
AustriaElvanse
BelgiumElvanse
DenmarkElvanse
SpainElvanse
FinlandElvanse
NetherlandsElvanse
IrelandTyvense
LuxembourgElvanse
NorwayElvanse
PortugalElvanse
SwedenElvanse
United Kingdom (Northern Ireland) Elvanse
Last review date of this leaflet:12/2023.
Detailed and updated information about this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.